Identifying early symptoms of hand osteoarthritis

A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis

Not applicable Interventional University Hospital, Montpellier · NCT03650673

This study is trying to find early signs of hand osteoarthritis in people under 60 using advanced imaging to help identify those at risk for worsening symptoms.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment150 (estimated)
Ages18 Years to 60 Years
SexAll
SponsorUniversity Hospital, Montpellier Academic / other
Locations1 site (Montpellier)
Trial IDNCT03650673 on ClinicalTrials.gov

What this trial studies

This study aims to identify early onset symptoms in patients suffering from hand osteoarthritis using advanced imaging techniques such as ultrasound and MRI. By focusing on patients under 60 years old with specific clinical and radiological criteria, the study seeks to identify subgroups at high risk for disease progression. The primary endpoint is to specify patients who show signs of radiological progression through X-ray assessments. This prospective cohort approach will help in understanding the early stages of hand osteoarthritis.

Who should consider this trial

Good fit: Ideal candidates for this study are individuals under 60 years old who exhibit early symptoms of hand osteoarthritis as defined by specific clinical and radiological criteria.

Not a fit: Patients with rheumatoid arthritis, inflammatory rheumatism, or advanced stages of osteoarthritis may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to earlier diagnosis and targeted interventions for patients with hand osteoarthritis, potentially improving their quality of life.

How similar studies have performed: While there have been studies focusing on osteoarthritis, this specific approach using imaging techniques for early identification of hand osteoarthritis symptoms is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Early digital osteoarthritis must combine the clinical AND radiological definition.

Clinical definition:

At least one of the following 4 criteria: Pain or stiffness or swelling or deformity of a digital joint (IPP and / or IPD) A breach of at least one PPI and / or IPD Age under 60 at the time of the first symptoms Clinical symptoms have been changing for less than 3 years

Radiographic definition:

The presence of the achievement of at least one PPI and / or IPD. Presence of at least two of the following three criteria: pinching, marginal subchondral condensation, marginal osteophyte Erosion on radiography is not an exclusion criteria

\- Consent form signed

Exclusion criteria:

* patients suffering from rheumatoid arthritis, rheumatoid psoriasis or any other inflammatory rheumatism
* patients suffering from metabolic diseasis such as gout, hemochromatosis, Wilson's disease; or from congenital disease such as displasie, osteogenesis,
* Presence of advanced radiographic osteoarthritis based in Kellgreen Lawrence score (=4) in one joint among the 10 previous sites.
* Not able to provide a sample of blood for any reasons
* MRI contraindication
* Being in exclusion period determined by another previous study
* Subject non affiliated to social insurance
* Pregnant or lactating women
* Vulnerable people based in L1121-5 article of CSP
* Elderly subject or protected subjects disabled to give their consent
* Subjects private of freedom by court or administrative order

Where this trial is running

Montpellier

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Hand OsteoarthritisHand osteoarthritisProspective cohortCartilageMobility
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.